Susquehanna International Group, LLP Precigen, Inc. Put Options Transaction History

Susquehanna International Group, LLP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$0.91 - $1.88 $9,373 - $19,364	-10,300 Reduced 26.68%	28,300 $26,000
Q2 2024 Aug 15, 2024	BUY	$1.27 - $1.75 $21,717 - $29,925	17,100 Added 79.53%	38,600 $60,000
Q1 2024 May 07, 2024	BUY	$1.21 - $1.75 $26,015 - $37,625	21,500 New	21,500 $31,000
Q1 2023 May 16, 2023	BUY	$0.88 - $2.19 $55,264 - $137,532	62,800 Added 581.48%	73,600 $78,000
Q4 2022 Feb 14, 2023	SELL	$1.27 - $2.26 $49,022 - $87,235	-38,600 Reduced 78.14%	10,800 $16,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $15,792 - $31,248	-11,200 Reduced 18.48%	49,400 $105,000

144

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $171M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.